CHAMPION-AF Clinical Trial
CHAMPION-AF
WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation
1 other identifier
interventional
3,000
16 countries
141
Brief Summary
The primary objective of this study is to determine if left atrial appendage closure (LAAC) with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable atrial-fibrillation
Started Oct 2020
Longer than P75 for not_applicable atrial-fibrillation
141 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2020
CompletedFirst Posted
Study publicly available on registry
May 19, 2020
CompletedStudy Start
First participant enrolled
October 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
April 9, 2026
April 1, 2026
7.1 years
May 14, 2020
April 8, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
WATCHMAN FLX is non-inferior (NI) for the occurrence of stroke, cardiovascular death, and systemic embolism
non-inferiority
36-months
WATCHMAN FLX is superior for non-procedural bleeding (ISTH major bleeding and clinically relevant non-major bleeding)
superiority
36-months
WATCHMAN FLX is non-inferior (NI) for the occurrence of ischemic stroke and systemic embolism
non-inferiority
60-months
Secondary Outcomes (4)
The occurrence of ISTH major bleeding
60-months
The occurrence of cardiovascular (CV) death, all stroke, systemic embolism (SE), and non-procedural bleeding (ISTH major bleeding and clinically relevant non-major bleeding)
60-months
The occurrence of ISTH Major Bleeding
36-months
The occurrence of cardiovascular (CV) death, all stroke, systemic embolism (SE), and non-procedural bleeding (ISTH major bleeding and clinically relevant non-major bleeding)
36-months
Study Arms (2)
Device Group
EXPERIMENTALRandomized to WATCHMAN FLX Left Atrial Appendage Closure Device
Control Group
ACTIVE COMPARATORRandomized to non-vitamin K oral anticoagulant (NOAC)
Interventions
WATCHMAN FLX LAAC Device Implantation
Initiation or continuation of a NOAC drug
Eligibility Criteria
You may qualify if:
- The subject is of legal age to participate in the study per the laws of their respective geography
- The subject has documented non-valvular atrial fibrillation (i.e., atrial fibrillation in the absence of moderate or greater mitral stenosis or a mechanical heart valve)
- The subject has a calculated CHA2DS2-VASc (congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, stroke or transient ischemic attack (TIA), vascular disease, age 65 to 74 years, sex category) score of 2 or greater for men and 3 or greater for women
- The subject is deemed to be suitable for the protocol-defined pharmacologic regimens in both the test and control arms
- The subject or legal representative is able to understand and willing to provide written informed consent to participate in the trial
- The subject is able and willing to return for required follow-up visits and examinations
You may not qualify if:
- Subjects who are currently enrolled in another investigational study, except when the subject is participating in a mandatory governmental registry, or a purely observational registry with no associated treatments
- The subject requires long-term anticoagulation therapy for reasons other than AF-related stroke risk reduction, for example due to an underlying hypercoagulable state (i.e., even if the device is implanted, the subjects would not be eligible to discontinue OAC due to other medical conditions requiring chronic OAC therapy)
- The subject is contraindicated or allergic to oral anticoagulation medication and/or aspirin
- The subject is indicated for chronic P2Y12 platelet inhibitor therapy
- The subject had or is planning to have any cardiac or non-cardiac intervention or surgical procedure within 30 days prior to or 60 days after implant (including, but not limited to: cardioversion, percutaneous coronary intervention (PCI), cardiac ablation, cataract surgery, etc.)
- The subject had a prior stroke (of any cause, whether ischemic or hemorrhagic) or transient ischemic attack (TIA) within the 30 days prior to enrollment
- The subject has an active bleed
- The subject has a reversible cause of AF or transient AF
- The subject is absent of a left atrial appendage (LAA) or the LAA is surgically ligated
- The subject has had a myocardial infarction (MI) documented in the clinical record as either a non-ST elevation MI (NSTEMI) or as an ST-elevation MI (STEMI), with or without intervention, within 30 days prior to enrollment
- The subject has a history of atrial septal repair or has an atrial septal device (ASD)/patent foramen ovale (PFO) device
- The subject has an implanted mechanical valve prosthesis in any position
- The subject has a known contraindication to percutaneous catheterization procedure
- The subject has a known contraindication to transesophageal echo (TEE)
- The subject has a cardiac tumor
- +10 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (141)
Grandview Medical Center
Birmingham, Alabama, 35243, United States
University of Alabama at Birmingham
Birmingham, Alabama, 35294-6830, United States
Arizona Arrhythmia Research Center
Phoenix, Arizona, 85016, United States
Phoenix Cardiovascular Research Group
Phoenix, Arizona, 85018, United States
Scottsdale Healthcare - Shea
Scottsdale, Arizona, 85258, United States
Tucson Medical Center Healthcare
Tucson, Arizona, 85712, United States
Arrythmia Research Group
Jonesboro, Arkansas, 72401, United States
Sharp Chula Vista Medical Center
Chula Vista, California, 91911, United States
Marin General Hospital
Greenbrae, California, 94904, United States
Scripps Memorial Hospital
La Jolla, California, 92037, United States
Los Robles Hospital and Medical Center
Los Angeles, California, 91360, United States
El Camino Hospital
Mountain View, California, 94040, United States
Eisenhower Medical Center
Rancho Mirage, California, 92270, United States
Mercy General Hospital
Sacramento, California, 95819, United States
Santa Barbara Cottage Hospital
Santa Barbara, California, 93105, United States
St. John's Health Center
Santa Monica, California, 90404, United States
Colorado Springs Cardiologist, P.C.
Colorado Springs, Colorado, 80923, United States
Yale University School of Medicine
New Haven, Connecticut, 06473, United States
Christiana Hospital
Newark, Delaware, 19718, United States
Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
Manatee Memorial Hospital
Bradenton, Florida, 34205, United States
Bay Area Cardiology Associates, P.A.
Brandon, Florida, 33511, United States
Broward General Medical Center
Fort Lauderdale, Florida, 33316, United States
St. Vincent's Medical Center
Jacksonville, Florida, 32204, United States
Lakeland Regional Medical Center
Lakeland, Florida, 33805, United States
Baptist Hospital of Miami
Miami, Florida, 33176, United States
AdventHealth Orlando
Orlando, Florida, 32803, United States
Tallahassee Memorial Hospital
Tallahassee, Florida, 32308, United States
Piedmont Hospital
Atlanta, Georgia, 30309, United States
Emory University Hospital
Atlanta, Georgia, 30322, United States
Memorial Health University Medical Center
Savannah, Georgia, 31404, United States
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
Advocate Christ Medical Center
Oak Lawn, Illinois, 60453, United States
St. John's Hospital
Springfield, Illinois, 62701, United States
Franciscan Health Indianapolis
Indianapolis, Indiana, 46237, United States
Community Hospital
Munster, Indiana, 46321, United States
Mercy Hospital Medical Center
Des Moines, Iowa, 50314, United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
University of Kansas Hospital
Kansas City, Kansas, 66160, United States
Norton Hospital
Louisville, Kentucky, 40202, United States
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Lahey Clinic Hospital
Burlington, Massachusetts, 01805, United States
Charlton Memorial
Fall River, Massachusetts, 02720, United States
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, 01655, United States
Sparrow Health System - Sparrow Hospital
Lansing, Michigan, 48912, United States
William Beaumont Hospital
Royal Oak, Michigan, 48073, United States
Mercy Hospital
Coon Rapids, Minnesota, 55433, United States
Mayo Clinic Foundation
Rochester, Minnesota, 55905, United States
Centracare Heart and Vascular Center
Saint Cloud, Minnesota, 56303, United States
HealthEast St. Joseph's Hospital
Saint Paul, Minnesota, 55102, United States
North Mississippi Medical Center
Tupelo, Mississippi, 38801, United States
St. Luke's Hospital of Kansas City
Kansas City, Missouri, 64111, United States
Billings Clinic
Billings, Montana, 59101, United States
Bergan Cardiology
Omaha, Nebraska, 68124, United States
The Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
Catholic Medical Center
Manchester, New Hampshire, 03102, United States
Englewood Hospital and Medical Center
Englewood, New Jersey, 07631, United States
Kaleida Health
Buffalo, New York, 14203, United States
Mount Sinai Medical Center
New York, New York, 10029, United States
Columbia University Medical Center
New York, New York, 10032, United States
Rochester General Hospital
Rochester, New York, 14621, United States
St. Francis Hospital
Roslyn, New York, 11576, United States
Novant Health Presbyterian Medical Center
Charlotte, North Carolina, 28204, United States
University Hospitals of Cleveland
Cleveland, Ohio, 44106, United States
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
OhioHealth Research and Innovation Institute-Riverside Methodist Hospital
Columbus, Ohio, 43214, United States
Kettering Medical Center
Kettering, Ohio, 45429, United States
The Toledo Hospital
Toledo, Ohio, 43606, United States
Legacy Emanuel Hospital & Health Center
Portland, Oregon, 97227, United States
Pinnacle Health at Harrisburg Hospital
Harrisburg, Pennsylvania, 17101, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
York Hospital
York, Pennsylvania, 17403, United States
Trident Medical Center
Charleston, South Carolina, 29406, United States
Medical University of South Carolina
Columbia, South Carolina, 29204, United States
Lexington Medical Center
West Columbia, South Carolina, 29169, United States
Erlanger Medical Center
Chattanooga, Tennessee, 37403, United States
Methodist Le Bonheur Healthcare
Germantown, Tennessee, 38138, United States
Centennial Medical Center
Nashville, Tennessee, 37203, United States
Vanderbilt University Medical Center
Nashville, Tennessee, 37232-7235, United States
Texas Cardiac Arrhythmia Research
Austin, Texas, 78705, United States
Heart Hospital of Austin
Austin, Texas, 78756, United States
Memorial Hermann Memorial City Medical Center
Houston, Texas, 77024, United States
The Heart Hospital Baylor Plano
Plano, Texas, 75093, United States
Methodist Texsan Hospital
San Antonio, Texas, 78201-2009, United States
Christus Trinity Mother Frances Health System
Tyler, Texas, 75701, United States
Inova Fairfax Hospital
Falls Church, Virginia, 22042, United States
Virginia Commonwealth University Health System
Richmond, Virginia, 23219, United States
Providence Regional Medical Center Everett
Everett, Washington, 98201, United States
Swedish Medical Center
Seattle, Washington, 98122, United States
CHI Franciscan Health System
Tacoma, Washington, 98405, United States
PeaceHealth Southwest Medical
Vancouver, Washington, 98668, United States
Monongalia General Hospital
Morgantown, West Virginia, 26505, United States
Aurora St. Luke's Medical Center
Milwaukee, Wisconsin, 52315, United States
St. Vincent's Hospital-Sydney
Darlinghurst, New South Wales, Australia
Monash Medical Centre
Clayton, Victoria, 3168, Australia
Westmead Hospital
Bella Vista, Australia
Onze Lieve Vrouw Ziekenhuis
Aalst, 9300, Belgium
CHU de Charleroi
Charleroi, Belgium
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Institut universitaire de Cardiologie et de Pneumologie de Quebec
Québec, Canada
Aarhus University Hospital
Aarhus, 8200, Denmark
Hopital Cardiologique de Lyon
Bron, France
CHU Grenoble-Hopital Michallon
Grenoble, 38043, France
Hospital de la Pitie-Salpetriere
Paris, 75151, France
Charite, Campus Benjamin Franklin
Berlin, Germany
SANA Kliniken Oberfranken Coburg GmbH
Coburg, Germany
Herzzentrum Dresden GmbH
Dresden, Germany
St.Johann Nepomuk Katholisches Hospitalvereinigung Thüringen GmbH
Erfurt, Germany
Elisabeth Krankenhaus Essen
Essen, Germany
St. Katharinen Krankenhaus
Frankfurt, 60389, Germany
Cardiologicum Hamburg Praxis Wandsbek
Hamburg, Germany
Universitaetsklinikum Schleswig-Holstein
Lübeck, Germany
Klinikum der Ludwig-Maximilians-Universitat
München, Germany
Shaare Zedek Medical Center
Jerusalem, Israel
Sheba Medical Center
Ramat Gan, Israel
Fondazione Toscana Gabriele Monasterio
Pisa, PI, 56126, Italy
Azienda Ospedaliera Careggi
Florence, Italy
Ospedale Degli Infermi
Rivoli, 10098, Italy
Instituto Clinico Humanitas
Rozzano, Italy
Chiba University Hospital
Chiba, Chiba, Japan
Kokura Memorial Hospital
Kitakyushu-shi, Fukuoka, 802-8555, Japan
Iwate Medical University Hospital
Shiwa-gun, Iwate, 028-3695, Japan
Mitsui Memorial Hospital
Chiyoda-ku, Tokyo, Japan
Shonan Kamakura General Hospital
Okamoto, Japan
Kurashiki Central Hospital
Okayama, Japan
Toho University Ohashi Medical Center
Tokyo, Japan
Toyama University Hospital
Toyama, Japan
Toyohashi Heart Center
Toyohashi, Japan
University of Tsukuba Hospital
Tsukuba, Japan
St. Antonius Ziekenhuis
Nieuwegein, Netherlands
Poznan University of Medical Sciences
Długa, Poznań, Poland
King Fahed Medical City- Prince Salman Cardiac Center
Riyadh, Saudi Arabia
Hospital Álvaro Cunqueiro
Vigo, Pontevedra, Spain
Hospital de Leon
León, 24071, Spain
Hospital Clinico Salamanca
Salamanca, Spain
University Hospital Zurich
Zurich, 8091, Switzerland
Royal Sussex County Hospital
Brighton, United Kingdom
Glenfield Hospital
Leicester, United Kingdom
John Radcliffe Hospital
Oxford, United Kingdom
Related Publications (2)
Doshi SK, Kar S, Nair DG, Waggoner T, Agarwal H, Moussavian M, Kashani A, Oza S, Feldman L, Sadhu A, DeLurgio D, Alli O, Nielsen-Kudsk JE, Yamamoto M, Alkhouli M, Camm AJ, Coylewright M, Gibson CM, Granger CB, Gurol ME, Huber KC, Mansour M, Natale A, Pocock SJ, Reddy VY, Saliba WI, Asch FM, Wehrenberg S, Frost K, Christen T, Sutton BS, Stein KM, Leon MB, Ellenbogen KA; CHAMPION-AF Investigators. Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation. N Engl J Med. 2026 Mar 28. doi: 10.1056/NEJMoa2517213. Online ahead of print.
PMID: 41910347DERIVEDKar S, Doshi SK, Alkhouli M, Camm AJ, Coylewright M, Gibson MC, Granger CB, Gurol ME, Huber K, Mansour M, Nair DG, Natale A, Pocock SJ, Reddy VR, Saliba W, Christen T, Allocco DJ, Ellenbogen KA, Leon MB. Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation. Am Heart J. 2023 Oct;264:123-132. doi: 10.1016/j.ahj.2023.05.022. Epub 2023 Jun 4.
PMID: 37279840DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Marty Leon, MD
New York-Presbyterian Heart Valve Center/Columbia University Irving Medical Center
- STUDY CHAIR
Kenneth A Ellenbogen, MD
Virginia Commonwealth University
- PRINCIPAL INVESTIGATOR
Shephal Doshi, MD
Pacific Heart Institute and Providence St. John's Health Center
- PRINCIPAL INVESTIGATOR
Saibal Kar, MD
HCA Healthhcare /Los Robles Health System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2020
First Posted
May 19, 2020
Study Start
October 15, 2020
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
April 9, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL